Share on StockTwits

Research analysts at Jefferies Group began coverage on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) in a report released on Monday, reports. The firm set a “buy” rating and a $14.00 price target on the stock. Jefferies Group’s price objective would suggest a potential upside of 46.60% from the stock’s previous close.

Amphastar Pharmaceuticals (NASDAQ:AMPH) traded down 3.56% on Monday, hitting $9.21. 24,832 shares of the company’s stock traded hands. Amphastar Pharmaceuticals has a one year low of $6.67 and a one year high of $11.07. The stock’s 50-day moving average is $9.41 and its 200-day moving average is $9.41. The company has a market cap of $399.8 million and a P/E ratio of 47.04.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.